BRIEF published on 04/22/2025 at 22:05, 1 year 3 months ago Abivax welcomes Dr. Dominik Höchli to its Board of Directors Board Of Directors Abivax Phase 3 Immunology Dominik Höchli
PRESS RELEASE published on 04/22/2025 at 22:05, 1 year 3 months ago Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones Abivax announces details of Annual General Meeting on June 6, 2025, in Paris as it progresses towards key 2025 milestones, including Phase 3 ABTECT trials Annual General Meeting Abivax Clinical-stage Biotechnology Phase 3 ABTECT Trials 2025 Milestones
PRESS RELEASE published on 04/22/2025 at 22:00, 1 year 3 months ago Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors Abivax appoints Dominik Höchli, MD to Board of Directors, bringing extensive immunology expertise ahead of key Phase 3 data readout in ulcerative colitis in Q3 2025 Board Of Directors Abivax Ulcerative Colitis Dominik Höchli Phase 3 Data Readout
BRIEF published on 04/18/2025 at 18:05, 1 year 3 months ago ABIVAX: Share Capital and Voting Rights as of March 31, 2025 Euronext Paris Share Capital Voting Rights Actions Abivax
BRIEF published on 04/18/2025 at 18:05, 1 year 3 months ago ABIVAX: Details of Share Capital and Voting Rights as of March 31, 2025 Euronext Paris Share Capital Voting Rights Biotechnology Abivax
BRIEF published on 03/27/2025 at 18:05, 1 year 4 months ago ABIVAX: Update of share capital and voting rights Share Capital Voting Rights Biotechnology AMF Abivax
BRIEF published on 03/26/2025 at 22:10, 1 year 4 months ago Abivax publishes its 2024 financial reports Biotechnology AMF Abivax Financial Reports DRY
PRESS RELEASE published on 03/26/2025 at 22:05, 1 year 4 months ago Abivax publishes financial reports with the French and U.S. securities regulatory agencies Abivax publishes financial reports with French and U.S. securities regulatory agencies. The company filed its Universal Registration Document and Annual Report for 2024 Abivax Financial Reports Regulatory Agencies U.S. Securities French
BRIEF published on 03/24/2025 at 08:35, 1 year 4 months ago Abivax Publishes its Financial Results for 2024 Financial Results Biotechnology Research And Development Treasury Clinical Trials
PRESS RELEASE published on 03/24/2025 at 08:30, 1 year 4 months ago Abivax Announces Full Year 2024 Financial Results Abivax announces full year 2024 financial results, cash balance of EUR 144.2M, ABTECT trial progress. CEO optimistic about 2025 milestones and financial outlook Financial Results Cash Position Abivax ABTECT Trial Clinical Progress
Published on 08/11/2026 at 00:40, 4 hours 37 minutes ago CORRECTION FROM SOURCE: Fermi Announces Binding Lease Agreement with TensorWave
Published on 08/11/2026 at 00:25, 4 hours 52 minutes ago Empress Reports 2026 Second Quarter Financial Results
Published on 08/10/2026 at 23:35, 5 hours 42 minutes ago NioCorp Project to Expand Production to 8 Made-in-USA Critical Minerals Over a 40-Year Mine Life with an Estimated $4.1 Billion Pre-Tax NPV8%
Published on 08/10/2026 at 23:30, 5 hours 47 minutes ago Condor and Element79 Agree on Restructured Terms for Lucero Project
Published on 08/10/2026 at 23:25, 5 hours 52 minutes ago Ur-Energy Reports Second Quarter 2026 Results
Published on 08/10/2026 at 22:15, 7 hours 2 minutes ago Amrize Files Form 10-Q for Second Quarter 2026
Published on 08/10/2026 at 22:05, 7 hours 12 minutes ago Immunic Appoints Elena Ridloff to Board of Directors
Published on 08/10/2026 at 20:24, 8 hours 53 minutes ago EQS-Adhoc: PNE AG updates on ongoing sales process
Published on 08/10/2026 at 19:35, 9 hours 42 minutes ago Kontron AG: All conditions of the mandatory tender offer of Ennoconn Corporation are met – Settlement will take place shortly
Published on 08/10/2026 at 18:29, 10 hours 48 minutes ago Fuller, Smith & Turner PLC: Director/PDMR Shareholdings
Published on 08/10/2026 at 18:00, 11 hours 17 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 11:53, 17 hours 23 minutes ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:36, 17 hours 41 minutes ago GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 09:22, 19 hours 55 minutes ago Number of shares and voting rights - July 2026 (In French only)
